Use of amoxicillin-clavulanate and resistance in Escherichia coli over a 4-year period

Infection Control and Hospital Epidemiology

Volumn 19, Issue 9, 1998, Pages 653-656

  Natsch, Stephanie ^a   Conrad, Christian ^a   Hartmeier, Cora ^a   Schmid, Beat ^a  

^a Hospital of Schaffhausen   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID;

ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC RESISTANCE; ARTICLE; CROSS INFECTION; DRUG COMBINATION; DRUG USE; ENTEROBACTER INFECTION; HOSPITAL BED CAPACITY; HOSPITAL PHARMACY; HUMAN; INFECTION CONTROL; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PRACTICE GUIDELINE; SWITZERLAND; TIME; UTILIZATION REVIEW;

AMOXICILLIN-POTASSIUM CLAVULANATE COMBINATION; ANTIBIOTIC PROPHYLAXIS; CROSS INFECTION; DRUG RESISTANCE, MICROBIAL; DRUG THERAPY, COMBINATION; DRUG UTILIZATION REVIEW; ESCHERICHIA COLI INFECTIONS; HOSPITAL BED CAPACITY, 100 TO 299; HUMANS; INFECTION CONTROL; MICROBIAL SENSITIVITY TESTS; PHARMACY SERVICE, HOSPITAL; PRACTICE GUIDELINES; SWITZERLAND; TIME FACTORS;

EID: 0032158857     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.2307/30141529     Document Type: Article

References (22)

1. Buckwold FJ, Ronald AR Antimicrobial misuse - effects and suggestions for control. J Antimicrob Chemother 1979;5:129-136.
2. Hollmann M. Chemotherapeutic-bacteriological interdependences observed by use of a clinical anti-infective drug monitoring system. Eur J Clin Pharmacol 1980;17:101-109.
3. Daschner F, Langmaack H, Wiedemann B. Antibiotic resistance in intensive care unit areas. Infect Control 1983;4:382-387.
4. McGowan JE Jr. Antimicrobial resistance in hospital organisms and its relation to antibiotic use. Rev Infect Dis 1983;5:1033-1048.
5. McGowan JE Jr. Is antimicrobial resistance in hospital microorganisms related to antibiotic use? Bull NYAcad Med 1987;63:253-268.
6. McGowan JE Jr. Do intensive hospital antibiotic control programs prevent the spread of antibiotic resistance? Infect Control Hosp Epidemiol 1994;15:478-483.
7. Ma MY, Goldstein EJ, Friedman MH, Anderson MS, Mulligan ME. Resistance of gram-negative bacilli as related to hospital use of antimicrobial agents. Antimicrob Agents Chemother 1983;24:347-352.
8. Ballow CH, Schentag JJ. Trends in antibiotic utilization and bacterial resistance. Report of the national nosocomial resistance surveillance group. Diagn Microbiol Infect Dis 1992;15:37S-42S.
9. Richard P, Delangle MH, Merrien D, Barille S, Reynaud A, Minozzi C, et al. Fluoroquinolone use and fluoroquinolone resistance: is there an association? Clin Infect Dis 1994;19:54-59.
10. Sanders CC, Sanders WE Jr. Beta-lactam resistance in gram-negative bacteria: global trends and clinical impact. Clin Infect Dis 1992;15:824-839.
11. Henquell C, Sirot D, Chanal C, De Champs C, Chatron P, Lafeuille B, et al. Frequency of inhibitor-resistant TEM β-lactamases in E coli isolates from urinary tract infections in France. J Antimicrob Chemother 1994;34:707-714.
12. Wu PJ, Shannon K, Phillips I. Effect of hyperproduction of TEM-1 beta-lactamase on in vitro susceptibility of E coli to beta-lactam antibiotics. Antimicrob Agents Chemother 1994;38:494-498.
13. Martinez JL, Cercenado E, Rodriguez-Creixems M, Vincente-Perez MF, Delgado-Iribarren A, Baquero F. Resistance to beta-lactam-clavulanate. Lancet 1987;2:1473.
14. Reguera JA, Baquero F, Pérez-Diaz JC, Martinez JL: Factors determining resistance to β-lactam combined with β-lactamase inhibitors in E coli. J Antimicrob Chemother 1991;27:569-575.
15. Sirot D, Chanal C, Henquell C, Labia R, Sirot J, Cluzel R. Clinical isolates of E coli producing multiple TEM mutants resistant to beta-lactamase inhibitors. J Antimicrob Chemother 1994;33:1117-1126.
16. Zhou XY, Bordon F, Sirot D, Kitzis MD, Gutmann L. Emergence of clinical isolates of E coli producing TEM-1 derivatives or an oxa-1 beta-lactamase conferring resistance to beta-lactamase inhibitors. Antimicrob Agents Chemother 1994;38:1085-1089.
17. Blazquez J, Baquero MR, Canton R, Alos I, Baquero F. Characterization of a new TEM-type beta-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of E coli. Antimicrob Agents Chemother 1993;37:2059-2063.
18. Wust J, Auckenthaler R, Breer C, Frei R, Heinzer I, Kamm W. Antibiotika-Empfindlichkeit von gramnegativen Bakterien auf Intensivpflegestationen in der Schweiz. Schweiz Med Wochenschr 1994;124:1695-1700.
19. Kastanakis S, Tzimis L, Papadomanolaki E, Alevraki G, Tsouri A, Koutsouba D, et al. Resistance patterns of E coli in a general hospital on the island of Crete. Medical Microbiology Letters 1996;5:S79.
20. Kouppari G, Zaphiropoulou A, Tsirepa M, Xenos N, Deliyianni V, Dellagrammaticas H. Resistance of E coli isolated from neonates. Medical Microbiology Letters 1996;5:S83.
21. Mueller ML, Conrad C, Schmid B. Epidemiologische Datenanalyse im Krankenhaus: Einsatz eines online-computer systems zur automatisierten Erreger-und Resistenzstatistik. Krh.-Hyg. + Inf.verh. 1997;19:43-47.
22. Barry AL, Thornsberry C: Susceptibility tests: diffusion test procedures. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology. Washington, DC, American Society for Microbiology; 1991:1117-1125.